StockNews.AI
CNDT
StockNews.AI
2 hrs

Conduent Applies GenAI to Revolutionize Detection of Reportable Events and Sets New Standard for FDA Compliance

1. Conduent launched GenAI-powered event detection for healthcare compliance. 2. Solution improves reporting speed, accuracy, and consistency for FDA compliance. 3. Automates identification of reportable events from various customer interactions. 4. Enhances efficiency and reduces manual effort in compliance processes. 5. Positioned to transform Pharma and Life Sciences compliance landscape.

13m saved
Insight
Article

FAQ

Why Bullish?

The introduction of innovative AI solutions often leads to increased market confidence, similar to previous AI integrations in various sectors that resulted in stock price appreciation.

How important is it?

The development of this solution is significant for Conduent as it leverages cutting-edge AI, promises operational efficiencies, and targets a critical industry need, indicating a strong potential for future growth.

Why Long Term?

The integration of AI in healthcare compliance could position Conduent for sustained growth, drawing parallels to historical technology adoption trends that drive long-term increases in client base and revenue.

Related Companies

Powered by Microsoft Azure OpenAI, new solution automates reportable event detection for Pharma & Life Sciences companies across every customer channel

Conduent Incorporated (NASDAQ:CNDT), a global technology-driven business solutions and services company, today announced the launch of a new GenAI-powered reportable event detection solution that dramatically improves the identification of events and empowers healthcare companies to uphold the highest standards of patient safety, both of which are critically important.

Built on Microsoft Azure OpenAI, Conduent's reportable event detection solution enhances the speed, accuracy, and consistency to identify incidents that must be provided to the Food & Drug Administration (FDA) for compliance. These events include adverse reactions, product complaints, and usability issues that could arise across millions of customer interactions.

Why It Matters

Pharma and Life Science companies handle countless interactions with customers every day via emails, chats, voice calls, texts, faxes, and social and digital platforms, and within these interactions is vital information that potentially must be reported to the FDA.

Real-world examples of reportable events

  • A patient emailing about unexpected dizziness after taking a prescribed medication.
  • A caregiver calling to report a child's rash after using a topical cream.
  • A customer texting that their insulin pen malfunctioned during use.
  • A chatbot conversation revealing confusion over dosage instructions.
  • A social media post describing a broken inhaler or packaging defect.

Setting New Standard for Compliance

Quality control to ensure the highest standards of quality, accuracy, and compliance are met is typically a manual process that can only randomly evaluate a small percentage of customer interactions. This new GenAI-powered solution can review nearly 100% of interactions across all channels, using GenAI to analyze language, context, and compliance rules to revolutionize the identification of reportable events.

"Patient assistance programs and medical information engagements are complex and data-rich, which is perfect for GenAI," said Kimberly Marshall, Head of Commercial Solutions and Account Management at Conduent. "By combining AI with deep compliance expertise, we're helping clients report faster, more accurately, and more consistently while saving time and money."

This solution integrates GenAI with logical reasoning, AI-driven search, client-specific rules, training materials, and regulatory framework, backed by Conduent's infrastructure, to automate the capture and classification of reportable events.

Key Benefits:

  • Enhanced Efficiency: Streamlines the process of identifying reportable events, saving time and reducing manual efforts.
  • Quality and Consistency: Understands the variability of consumer language to better identify potential reportable events and product quality complaints, and provides consistent, high-quality reporting.
  • Regulatory Compliance: Enables adherence to FDA regulations and other compliance standards, minimizing the risk of penalties. Life Science companies can use the data to enhance their marketing strategies, product packaging and user experiences while ensuring compliance with FDA regulations.

The Conduent reportable event detection tool is another collaboration where Conduent leverages Microsoft Azure OpenAI to drive quality, improve customer experience, and save cost.

About Conduent

Conduent delivers digital business solutions and services spanning the commercial, government and transportation spectrum – creating valuable outcomes for its clients and the millions of people who count on them. The Company leverages cloud computing, artificial intelligence, machine learning, automation and advanced analytics to deliver mission-critical solutions. Through a dedicated global team of approximately 56,000 associates, process expertise and advanced technologies, Conduent's solutions and services digitally transform its clients' operations to enhance customer experiences, improve performance, increase efficiencies and reduce costs. Conduent adds momentum to its clients' missions in many ways including disbursing approximately $85 billion in government payments annually, enabling 2.3 billion customer service interactions annually, empowering millions of employees through HR services every year and processing nearly 13 million tolling transactions every day. Learn more at www.conduent.com.

Note: To receive RSS news feeds, visit www.news.conduent.com. For open commentary, industry perspectives and views, visit http://twitter.com/Conduent, http://www.linkedin.com/company/conduent or http://www.facebook.com/Conduent.

Trademarks

Conduent is a trademark of Conduent Incorporated in the United States and/or other countries. Other names may be trademarks of their respective owners.

Media:

Sean Collins, Conduent, +1-310-497-9205, sean.collins2@conduent.com

Investor Relations:

Joshua Overholt, Conduent, ir@conduent.com

Related News